These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 22291440

  • 1. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
    Ceraudo E, Hierso R, Tan YV, Murail S, Rouyer-Fessard C, Nicole P, Robert JC, Jamin N, Neumann JM, Robberecht P, Laburthe M, Couvineau A.
    FASEB J; 2012 May; 26(5):2060-71. PubMed ID: 22291440
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the new photoaffinity probe (Bz2-K24)-VIP.
    Tan YV, Couvineau A, Lacapere JJ, Laburthe M.
    Ann N Y Acad Sci; 2006 Jul; 1070():575-80. PubMed ID: 16888228
    [Abstract] [Full Text] [Related]

  • 3. Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.
    Ceraudo E, Tan YV, Couvineau A, Lacapere JJ, Laburthe M.
    Ann N Y Acad Sci; 2006 Jul; 1070():180-4. PubMed ID: 16888162
    [Abstract] [Full Text] [Related]

  • 4. VPAC1 receptor binding site: contribution of photoaffinity labeling approach.
    Couvineau A, Ceraudo E, Tan YV, Laburthe M.
    Neuropeptides; 2010 Apr; 44(2):127-32. PubMed ID: 20031208
    [Abstract] [Full Text] [Related]

  • 5. The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor.
    Ceraudo E, Tan YV, Nicole P, Couvineau A, Laburthe M.
    J Mol Neurosci; 2008 Nov; 36(1-3):245-8. PubMed ID: 18597186
    [Abstract] [Full Text] [Related]

  • 6. The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.
    Ceraudo E, Murail S, Tan YV, Lacapère JJ, Neumann JM, Couvineau A, Laburthe M.
    Mol Endocrinol; 2008 Jan; 22(1):147-55. PubMed ID: 17885205
    [Abstract] [Full Text] [Related]

  • 7. The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modeling.
    Couvineau A, Tan YV, Ceraudo E, Lacapère JJ, Murail S, Neumann JM, Laburthe M.
    Ann N Y Acad Sci; 2006 Jul; 1070():205-9. PubMed ID: 16888167
    [Abstract] [Full Text] [Related]

  • 8. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I.
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [Abstract] [Full Text] [Related]

  • 9. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC, Rouyer-Fessard C, Couvineau A, Nicole P, Devaud H, El Benna J, Laburthe M.
    Mol Pharmacol; 2003 Dec; 64(6):1565-74. PubMed ID: 14645688
    [Abstract] [Full Text] [Related]

  • 10. Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP.
    Tan YV, Couvineau A, Laburthe M.
    J Biol Chem; 2004 Sep 10; 279(37):38889-94. PubMed ID: 15247290
    [Abstract] [Full Text] [Related]

  • 11. Generation of PEGylated VPAC1-selective antagonists that inhibit proliferation of a lung cancer cell line.
    Pan CQ, Hamren S, Roczniak S, Tom I, DeRome M.
    Peptides; 2008 Mar 10; 29(3):479-86. PubMed ID: 17942192
    [Abstract] [Full Text] [Related]

  • 12. Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling.
    Tan YV, Couvineau A, Murail S, Ceraudo E, Neumann JM, Lacapère JJ, Laburthe M.
    J Biol Chem; 2006 May 05; 281(18):12792-8. PubMed ID: 16520374
    [Abstract] [Full Text] [Related]

  • 13. Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor.
    Tan YV, Couvineau A, Van Rampelbergh J, Laburthe M.
    J Biol Chem; 2003 Sep 19; 278(38):36531-6. PubMed ID: 12807902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
    Nicole P, Du K, Couvineau A, Laburthe M.
    J Pharmacol Exp Ther; 1998 Feb 19; 284(2):744-50. PubMed ID: 9454823
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.